In thyroid cancer FTC-133 cells, it was confirmed that FOXD3-AS1 promotes cell proliferation by functioning as a miRNA sponge of miR-296-5p and therefore activating the TGF-β1/Smads signaling pathway (40). This evidence concerns the gene FOXD3 and thyroid gland carcinoma.